Our results indicated that adjuvant SFI CT is beneficial for outcome indicators such as response rate, KPS score, CD3+, CD4+, CD4+/CD8+, NK cells, leukopenia, and gastrointestinal reactions in patients with BC. This evidence concerns the gene CD4 and breast cancer.